H1-antihistamines for the treatment of anaphylaxis with and without shock
Country of origin: USA
Click for Full Details: www.mrw.interscience.wiley.comAnaphylaxis is a rare, but potentially life-threatening emergency. Evidence suggests that incidence may be increasing rapidly. Common triggers of anaphylaxis include a variety of foods, drugs and insect venoms.
H1-antihistamines are commonly used for the emergency treatment of anaphylaxis although the evidence underpinning this treatment is unclear. A systematic review of the literature has been conducted, searching key databases for high quality published and unpublished material on this subject; in addition, experts in this area and relevant pharmaceutical companies were contacted.
The searches failed to retrieve any randomised controlled trials on this subject. The review concludes there is no evidence from randomised controlled trials to support the use of H1-antihistamines in the emergency management of anaphylaxis.
The Cochrane review is available online.
Click for Full Details: www.mrw.interscience.wiley.com
Calculate by QxMD March 2018
ECG Guide QxMD Medical Software March 2018
Read by QxMD March 2018
Pedi STAT March 2018
Better access to medicine safety data March 2018
ACEP Toxicology February 2018
STD Treatment (Tx) Guidelines mobile app February 2018
EMRA PressorDex for emergency medicine physicians February 2018
BMJ Best Practice February 2018
Orlive Surgical Broadcasts February 2018